Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Zhu, Wenjuan  [Clear All Filters]
2024
Gao L, Yang L, Zhou S, Zhu W, Han Y, Chen S, Xue S, Wang Y, Qiu H, Wu D, et al. Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study. Stem Cell Res Ther. 2024;15(1):24.
Wei X, Zhu W, Li J, Zhou S, Zhu Q, Ma X, Han Y, Wang Y, Miao M, Qiu H, et al. The role of pre-existing anti-HLA antibodies in severe aplastic anemia patients undergoing allogenic hematopoietic stem cell transplantation. Transplant Cell Ther. 2024.
2023
Li S, Ge J, Zhou S, Zhu W, Han Y, Chen S, Xue S, Wang Y, Qiu H, Wu X, et al. CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr vir. Clin Transl Med. 2023;13(10):e1459.
Zhu W, Liu W, Yu R, Manning M, Romfh AWaran, Wu JC. Generation of two induced pluripotent stem cell lines from patients with Down syndrome. Stem Cell Res. 2023;72:103204.
2022
Zhu W, Wang C, Mullapudi N, Cao Y, Li L, Lo IFai Man, Tsui SKwok-Wing, Chen X, Lei Y, Gu S. A robust pipeline for ranking carrier frequencies of autosomal recessive and X-linked Mendelian disorders. NPJ Genom Med. 2022;7(1):72.